INITIAL combination therapy with vildagliptin/metformin in drug-naive Asian type 2 diabetes patients: influence of age, BMI and co-morbidities in a real world setting

被引：0
|
作者：
Mirasol, R. C. [1 ]
Pathan, M. F. [2 ]
Chawla, M. [3 ]
Kim, T. H. [4 ]
Cooke, K. [5 ]
Hours-Zesiger, P. [5 ]
Shete, A. [5 ]
机构：
[1] St Lukes Med Ctr, Quezon City, Philippines
[2] BIRDEM Hosp, Dhaka, Bangladesh
[3] LINA Diabet Care Ctr, Mumbai, Maharashtra, India
[4] Seoul Med Ctr, Seoul, South Korea
[5] Novartis Pharma AG, Basel, Switzerland
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
774
引用
收藏
页码：S355 / S355
页数：1
相关论文
共 50 条
  • [21] Physicians' intention and actual pattern of treatment in drug-naive patients with type 2 diabetes in the real-world setting in Japan
    Murayama, H.
    Imai, K.
    Bauer, I.
    Odawara, M.
    DIABETOLOGIA, 2018, 61 : S371 - S371
  • [22] Vildagliptin is as effective as rosiglitazone in drug-naive patients with type 2 diabetes and does not cause weight gain
    Schweizer, A.
    Dejager, S.
    Baron, M. A.
    Mills, D.
    Amiour, Y.
    Rosenstock, J.
    DIABETOLOGIA, 2006, 49 : 479 - 479
  • [23] Epigenetic markers associated with metformin response and intolerance in drug-naive patients with type 2 diabetes
    Garcia-Calzon, Sonia
    Perfilyev, Alexander
    Martinell, Mats
    Ustinova, Monta
    Kalamajski, Sebastian
    Franks, Paul W.
    Bacos, Karl
    Elbere, Ilze
    Pihlajamaki, Jussi
    Volkov, Petr
    Vaag, Allan
    Groop, Leif
    Maziarz, Rlena
    Klovins, Janis
    Ahlqvist, Emma
    Ling, Charlotte
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (561)
  • [24] ADHERENCE TRAJECTORIES IN MEDICAID DRUG-NAIVE TYPE 2 DIABETES PATIENTS: A COMPARATIVE STUDY BETWEEN INITIAL COMBINATION THERAPY AND STEP-THERAPY APPROACHES
    Fatima, B.
    Majd, Z.
    Abughosh, S.
    VALUE IN HEALTH, 2024, 27 (06) : S364 - S364
  • [25] Efficacy and tolerability of initial combination therapy with nateglinide and metformin in treatment-naive patients with type 2 diabetes
    Horton, ES
    Foley, JE
    Shen, SG
    Baron, MA
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (06) : 883 - 889
  • [26] Real-world Retrospective Assessment of Initiation and Effectiveness of Dual Combination Therapy with Metformin and Teneligliptin in Drug Naive Indian Type 2 Diabetes Mellitus Patients
    Chadha, Manoj
    Banzal, Subodh
    Sridhar, S.
    Goswami, Soumik
    Barkate, Hanmant
    Suryawanshi, Sachin
    Jadhav, Mayur
    Brid, Manasi
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (01) : OC16 - OC19
  • [27] The Combination Therapy With Metformin and Vildagliptin Decreases Lymphocytes Count in patients With Type 2 Diabetes Mellitus
    Zografou, Ioanna
    Sampanis, Christos
    Papageorgiou, Athanasios
    Nikolaidou, Barbara
    Doukelis, Panagiotis
    Papadopoulou, Despina
    Doumas, Michael
    Douma, Stella
    DIABETES, 2012, 61 : A600 - A600
  • [28] Efficacy and tolerability of vildagliptin in drug-naive patients with type 2 diabetes (T2DM) and mild hyperglycemia
    Scherbaum, W. A.
    Schweizer, A.
    Mari, A.
    Nilsson, P. M.
    Lalanne, G.
    Jauffret, S.
    Foley, J. E.
    DIABETES, 2007, 56 : A134 - A134
  • [29] Comparison between vildagliptin and metformin to sustain reductions in HbA1c over 1 year in drug-naive patients with Type 2 diabetes
    Schweizer, A.
    Couturier, A.
    Foley, J. E.
    Dejager, S.
    DIABETIC MEDICINE, 2007, 24 (09) : 955 - 961
  • [30] Effectiveness of vildagliptin as add-on to metformin monotherapy among uncontrolled type 2 diabetes mellitus patients in a real-world setting
    Melzer Cohen, Cheli
    Davis, Carla
    Shalev, Varda
    Chodick, Gabriel
    JOURNAL OF DIABETES, 2018, 10 (01) : 68 - 72
12345